Back to companies
Vivos Therapeutics, Inc.
VVOSUSNASDAQPharmaceuticals & HealthcareVivos Therapeutics, Inc.
Revenue
$17.4mn
YoY +16.0%
Operating income
-$19.9mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API